Antibody Identification Software

Antibody Identification Software

Antibody Identification Software

Antibody identification is one of your lab’s most complex tasks. ORTHO RESOLVIGEN™ is expert software that supports this expertise in your lab by providing information and guidance to help enable your lab personnel to evaluate results and make informed decisions.

Sales Support



Request sales information  
Help enable your lab staff with the confidence of an expert immunohematologist by their side

Paired with the ORTHO VISION™ Analyzer, the ORTHO RESOLVIGEN™ 4 software update further automates antibody identification and improves user experience in an easy, efficient, and complete way.


  • Redesigned Interface: The RESOLVIGEN™ 4 user interface is now more intuitive and much easier to navigate
  • Clarified explanation of results: Within the RESOLVIGEN™ 4 software, different antigen expressions as well as different reaction intensities are marked with tags. Strong and weak reactivity and the associated reasons for exclusions of antibodies are also marked.
  • Report customization: Reports for patients, tests, rare RBCs, and panels can now be customized in RESOLVIGEN™ 4
  • Network ready: RESOLVIGEN™ 4 does not require special installation, and can integrate with a client server database to allow sharing of data among several computers


  • Total automation: RESOLVIGEN™ 4 automates the antibody identification testing process from order to transfer to LIS
  • Standardized diagnosis: A diagnosis may now be entered into RESOLVIGEN™ 4 in a standard format that can be readily exported to LIS, which in turn standardizes interpretation of results
  • Rare red blood cell: RESOLVIGEN™ 4 allows you to create a rare blood cell bank—an archive with public and private antigens that can be searched by different criteria and used to solve complex identification
  • e-Antigram availability: There is also easy access to downloadable antigram data that can be uploaded into the RESOLVIGEN™ 4 software to decrease clerical errors


  • Over 300 antibodies: RESOLVIGEN™ 4 interprets antibody identification results of 322 antibodies with serological and clinical information and bibliography references
  • Over 40 procedures: RESOLVIGEN™ 4 provides access to more than 40 immunohematology procedures to assist resolution of complex serological cases
  • Additional tests: RESOLVIGEN™ 4 suggests additional tests to confirm or exclude the presence of an antibody
  • Enhanced reactions: RESOLVIGEN™ 4 suggests supplemental methods to enhance the reaction of very weak antibodies or identify very complex patterns
  • Improved clarity: RESOLVIGEN™ 4 provides the reasoning behind how the software identified the correct antibodies with an updated reference library to support the conclusion
  • Database creation: RESOLVIGEN™ 4 creates a complete database including images of all immunized patients on a local, departmental, or regional level


  • Is compatible and integrates with both ORTHO AutoVue® Innova System and ORTHO VISION™ Analyzer
  • Can also operate in a stand-alone configuration
  • Works with ORTHO Antibody Identification Panels (ORTHO RESOLVE® Panel A, ORTHO RESOLVE® Panel B, and ORTHO RESOLVE® Panel C – 0.8% or 3%) and Antibody Screening Panels (SURGISCREEN®, SELECTOGEN®, or BioVue® Screen)


For IFUs, MSDSs, and other technical documentation, see Technical Documents   

Related Products and Services


Respond to the unique challenges in your lab with the first-ever system with Responsive Automation

Learn more  


Help to safely, accurately, and efficiently screen patients—and deliver fast, accurate, standardized results, with proven and reliable reagents that integrate with the entire line of ORTHO products.

Learn more  


Gain access to the latest educational content from the leading professionals in transfusion medicine in a 24/7/365 virtual trade show and online learning environment

Learn more   
© Ortho Clinical Diagnostics 2019. Ortho Clinical Diagnostics, publishes this site and is solely responsible for its content. The availability of the products is subject to compliance with the regulatory requirements of each market.